You are here

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists

Authors

Citation

Ottaviano M, Curvietto M, Rescigno P On behalf of SCITO (Società Campana di ImmunoTerapia Oncologica), et al
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
Journal for ImmunoTherapy of Cancer 2020;8:e001154. doi: 10.1136/jitc-2020-001154
Online issue publication 
October 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.